BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1344815)

  • 21. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signet ring-like cells: no longer a "signature" of glandular differentiation.
    Lortscher DN; Satter EK; Romero LS
    Dermatol Online J; 2012 Apr; 18(4):3. PubMed ID: 22559018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").
    Barnhill RL; Argenyi Z; Berwick M; Duray PH; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Paine S; Piepkorn MW; Prieto V; Rabkin MS; Schmidt B; Selim A; Shea CR; Trotter MJ
    Am J Surg Pathol; 2008 Jan; 32(1):36-44. PubMed ID: 18162768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoid-like pattern in melanoma: report of 4 cases.
    Kacerovska D; Michal M; Sosna B; Cempirkova D; Ambrus M; Richtr P; Danis D; Zelger B; Kazakov DV
    Am J Dermatopathol; 2009 Aug; 31(6):542-50. PubMed ID: 19590421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.
    Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P
    Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of signet-ring cell carcinoma of the gallbladder: immunohistochemistry and differential diagnosis.
    Pavić I; Marusić Z; Mijić A; Balicević D; Kruslin B; Tomas D
    Acta Clin Croat; 2010 Jun; 49(2):159-62. PubMed ID: 21086733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
    Thomas AA; Stephenson AJ; Campbell SC; Jones JS; Hansel DE
    Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signet ring squamous cell carcinoma--the forgotten variant: case report and review of the literature.
    El Demellawy D; Onuma K; Alowami S
    J Cutan Pathol; 2011 Mar; 38(3):306-8. PubMed ID: 19751229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
    Raju U; Ma CK; Shaw A
    Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Triggered trap": nevoid malignant melanoma.
    McNutt NS
    Semin Diagn Pathol; 1998 Aug; 15(3):203-9. PubMed ID: 9711670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanocytic nevi clinically simulating melanoma.
    Makino E; Uchida T; Matsushita Y; Inaoki M; Fujimoto W
    J Dermatol; 2007 Jan; 34(1):52-5. PubMed ID: 17204102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary cutaneous signet-ring cell melanoma with pseudoglandular features, spindle cells and oncocytoid changes.
    Kacerovska D; Sokol L; Michal M; Kazakov DV
    Am J Dermatopathol; 2009 Feb; 31(1):81-3. PubMed ID: 19155732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrointestinal stromal tumors with prominent signet-ring cell features.
    Suster S; Fletcher CD
    Mod Pathol; 1996 Jun; 9(6):609-13. PubMed ID: 8782196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.
    Kittler H; Pehamberger H; Wolff K; Binder M
    J Am Acad Dermatol; 2000 Sep; 43(3):467-76. PubMed ID: 10954658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical characteristics of melanoma.
    Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
    J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
    Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
    Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary cutaneous signet-ring cell melanoma: a clinico-pathologic and immunohistochemical study of two cases.
    Rütten A; Huschka U; Requena C; Rodríguez-Peralto JL; Requena L
    Am J Dermatopathol; 2003 Oct; 25(5):418-22. PubMed ID: 14501290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signet ring cell melanocytic nevus: report of a case over trichilemmal cyst and review of the literature.
    Sabater Marco V; Escutia Muñoz B; Morera Faet A; Botella Estrada R
    Am J Dermatopathol; 2012 Feb; 34(1):e10-4. PubMed ID: 22262365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Uncommon variants of malignant melanocytic neoplasms].
    Mentzel T
    Pathologe; 2007 Nov; 28(6):445-52. PubMed ID: 17846776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anti-MAGE antibody B57 as a diagnostic marker in melanocytic lesions.
    Kazakov DV; Kutzner H; Rütten A; Michal M; Requena L; Burg G; Dummer R; Kempf W
    Am J Dermatopathol; 2004 Apr; 26(2):102-7. PubMed ID: 15024190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.